XML 233 R42.htm IDEA: XBRL DOCUMENT v3.24.0.1
Financial Assets & Liabilities (Tables)
12 Months Ended
Dec. 31, 2023
Investments, All Other Investments [Abstract]  
Financial assets and financial liabilities measured at fair value on a recurring basis
The following table presents the company’s financial assets and financial liabilities that are measured at fair value on a recurring basis at December 31, 2023 and 2022.
($ in millions)
Fair Value20232022
At December 31:Hierarchy Level
Assets (6)
Liabilities (7)
Assets (6)
Liabilities (7)
Cash equivalents (1)
Time deposits and certificates of deposit (2)
2$7,206 N/A$3,712 N/A
Money market funds1494 N/A306 N/A
Total cash equivalents$7,699 N/A$4,018 N/A
Equity investments
125 N/A— N/A
Debt securities–current (2)(3)
2373 N/A852 N/A
Debt securities–noncurrent (2)(4)
2,3N/A31 N/A
Derivatives designated as hedging instruments
Interest rate contracts2299 336 
Foreign exchange contracts2131 275 184 674 
Derivatives not designated as hedging instruments
Foreign exchange contracts (5)
2115 19 42 16 
Equity contracts
293 — 49 
Total$8,446 $593 $5,179 $1,034 
(1)Included within cash and cash equivalents in the Consolidated Balance Sheet.
(2)Available-for-sale debt securities with carrying values that approximate fair value.
(3) U.S. treasury bills and term deposits that are reported within marketable securities in the Consolidated Balance Sheet.
(4)Includes immaterial activity related to private company investments reported within investments and sundry assets in the Consolidated Balance Sheet.
(5)2023 assets include $62 million related to foreign exchange call option contracts entered into in connection with the planned acquisition of StreamSets and webMethods from Software AG. Refer to note T, “Derivative Financial Instruments,” for additional information.
(6)The gross balances of derivative assets contained within prepaid expenses and other current assets, and investments and sundry assets in the Consolidated Balance Sheet at December 31, 2023 were $304 million and $37 million, respectively, and at December 31, 2022 were $271 million and $7 million, respectively.
(7)The gross balances of derivative liabilities contained within other accrued expenses and liabilities, and other liabilities in the Consolidated Balance Sheet at December 31, 2023 were $294 million and $299 million, respectively, and at December 31, 2022 were $546 million and $488 million, respectively.
N/A–Not applicable